Company Filing History:
1 out of 14 
1 out of 19 
Years Active: 2022
Title: Desirée González Callejas: Innovator in Injectable Melatonin Composition
Introduction
Desirée González Callejas is a notable inventor based in Granada, Spain. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on melatonin compositions. His research focuses on creating stable injectable formulations that can enhance therapeutic applications.
Latest Patents
González Callejas holds a patent for a "Durable preparation of an injectable of melatonin exhibiting long-term stability." This invention relates to an aqueous melatonin composition that demonstrates remarkable long-term stability while allowing for high concentrations of this water-insoluble active ingredient. The properties of this composition make it particularly useful for intravenous administration, providing a new avenue for melatonin's therapeutic use.
Career Highlights
Throughout his career, Desirée González Callejas has worked with prominent institutions such as the Servicio Andaluz de Salud and the Universidad de Granada. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to advancements in medical science.
Collaborations
Some of his notable collaborators include Darío Acuña Castroviejo and Germaine Escames Rosa. Their joint efforts have furthered the research and development of innovative pharmaceutical solutions.
Conclusion
Desirée González Callejas is a pioneering inventor whose work on injectable melatonin compositions has the potential to transform therapeutic practices. His contributions to the field highlight the importance of innovation in medicine.